These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1885733)

  • 1. Fine serotyping of human immunodeficiency virus serotype 1 (HIV-1) and HIV-2 infections by using synthetic oligopeptides representing an immunodominant domain of HIV-1 and HIV-2/simian immunodeficiency virus.
    Baillou A; Janvier B; Leonard G; Denis F; Goudeau A; Barin F
    J Clin Microbiol; 1991 Jul; 29(7):1387-91. PubMed ID: 1885733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-directed serology using synthetic oligopeptides representing the C-terminus of the external glycoproteins of HIV-1, HIV-2, or SIVmac may distinguish subtypes among primate lentiviruses.
    Baillou A; Janvier B; Mayer R; Kanki P; M'Boup S; Denis F; Goudeau A; Essex M; Barin F
    AIDS Res Hum Retroviruses; 1991 Sep; 7(9):767-71. PubMed ID: 1720632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.
    Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G
    AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of human immunodeficiency virus type 1 subtype on HIV antibody detection in Burkina Faso.
    Gautier-Charpentier L; Ouedraogo-Traoré R; Simonon A; Meda N; Kpozehouen A; Dahourou H; Soudré R; Van de Perre P; Barin F
    J Acquir Immune Defic Syndr; 2001 Oct; 28(2):194-5. PubMed ID: 11588515
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of linear antigenic sites in the envelope proteins of human immunodeficiency virus (HIV) type 2 and type 1.
    Norrby E; Putkonen P; Böttiger B; Utter G; Biberfeld G
    AIDS Res Hum Retroviruses; 1991 Mar; 7(3):279-85. PubMed ID: 1712215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic and immunogenic sites of HIV-2 glycoproteins.
    Chiodi F; Björling E; Samuelsson A; Norrby E
    Chem Immunol; 1993; 56():61-77. PubMed ID: 8452654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates.
    Robert-Guroff M; Aldrich K; Muldoon R; Stern TL; Bansal GP; Matthews TJ; Markham PD; Gallo RC; Franchini G
    J Virol; 1992 Jun; 66(6):3602-8. PubMed ID: 1374810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New multiple antigenic peptide-based enzyme immunoassay for detection of simian immunodeficiency virus infection in nonhuman primates and humans.
    Ndongmo CB; Switzer WM; Pau CP; Zeh C; Schaefer A; Pieniazek D; Folks TM; Kalish ML
    J Clin Microbiol; 2004 Nov; 42(11):5161-9. PubMed ID: 15528710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and differentiation of HIV-1 group O sera from HIV-1 group M and HIV-2 using recombinant antigens and peptides.
    Hickman RK; Vallari A; Golden A; Lund J; Hackett J; Brennan C; Devare S
    J Virol Methods; 1998 May; 72(1):43-9. PubMed ID: 9672131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of simian immunodeficiency virus and human immunodeficiency virus type 2 capsid antigens by a monoclonal antibody-based antigen capture assay.
    Lairmore MD; Hofheinz DE; Letvin NL; Stoner CS; Pearlman S; Toedter GP
    AIDS Res Hum Retroviruses; 1993 Jun; 9(6):565-71. PubMed ID: 7688521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neutralization relationship of HIV type 1, HIV type 2, and SIVcpz is reflected in the genetic diversity that distinguishes them.
    Nyambi PN; Willems B; Janssens W; Fransen K; Nkengasong J; Peeters M; Vereecken K; Heyndrickx L; Piot P; van der Groen G
    AIDS Res Hum Retroviruses; 1997 Jan; 13(1):7-17. PubMed ID: 8989422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing modified and plain peptide linked enzyme immunosorbent assay (ELISA) for detection of human immunodeficiency virus type-1 (HIV-1) and type-2 (HIV-2) antibodies.
    Manocha M; Chitralekha KT; Thakar M; Shashikiran D; Paranjape RS; Rao DN
    Immunol Lett; 2003 Feb; 85(3):275-8. PubMed ID: 12663143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160.
    Benjouad A; Gluckman JC; Montagnier L; Bahraoui E
    J Virol; 1993 Mar; 67(3):1693-7. PubMed ID: 7679751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing of novel antigenic peptide cocktail for the detection of antibodies to HIV-1/2 by ELISA.
    Tiwari RP; Jain A; Khan Z; Kumar P; Bhrigu V; Bisen PS
    J Immunol Methods; 2013 Jan; 387(1-2):157-66. PubMed ID: 23098841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological reactivities of Ghanaian sera with HIV-1, HIV-2, and simian immunodeficiency virus SIVagm.
    Kawamura M; Ishikawa K; Mingle JA; Osei-Kwasi M; Afoakwa SN; Nettey VB; Chosa T; Hayami M
    AIDS; 1989 Sep; 3(9):609-11. PubMed ID: 2551342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent cellular cytotoxicity detects type- and strain-specific antigens among human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus SIVmac isolates.
    Ljunggren K; Biberfeld G; Jondal M; Fenyö EM
    J Virol; 1989 Aug; 63(8):3376-81. PubMed ID: 2746734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus (HIV) antigen-antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection.
    Weber B
    J Clin Microbiol; 2002 Nov; 40(11):4402-3; author reply 4403-4. PubMed ID: 12409446
    [No Abstract]   [Full Text] [Related]  

  • 18. Subtyping of human immunodeficiency virus type 1 strains by using antibodies specific for the third variable domain (V3) of gp120: results may be affected by divergent V3 sequences.
    Sherefa K; Sällberg M; Johansson B; Salminen M; Sönnerborg A
    J Clin Microbiol; 1997 Sep; 35(9):2419-21. PubMed ID: 9276430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses.
    Simon F; Souquière S; Damond F; Kfutwah A; Makuwa M; Leroy E; Rouquet P; Berthier JL; Rigoulet J; Lecu A; Telfer PT; Pandrea I; Plantier JC; Barré-Sinoussi F; Roques P; Müller-Trutwin MC; Apetrei C
    AIDS Res Hum Retroviruses; 2001 Jul; 17(10):937-52. PubMed ID: 11461679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive enzyme-immunoassays using native viral antigens to discriminate between HIV-1 and HIV-2 infections.
    Baillou A; Barin F; Léonard G; Denis F; Petat E; Canas Ferreira WF; M'Boup S; Goudeau A
    J Virol Methods; 1990 Jul; 29(1):81-9. PubMed ID: 2211958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.